Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy.

about

Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy.

Item

http://www.wikidata.org/entity/Q42979490

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Prediction of virologic respon ...... interferon induction therapy.

@en

Prediction of virologic respon ...... interferon induction therapy.

@nl

type

Item

label

Prediction of virologic respon ...... interferon induction therapy.

@en

Prediction of virologic respon ...... interferon induction therapy.

@nl

prefLabel

Prediction of virologic respon ...... interferon induction therapy.

@en

Prediction of virologic respon ...... interferon induction therapy.

@nl

P1476

Prediction of virologic respon ...... interferon induction therapy.

@en

P2093

Christine J Weegink

http://www.w3.org/2001/XMLSchema#string

Hans L Zaaijer

http://www.w3.org/2001/XMLSchema#string

Henk W Reesink

http://www.w3.org/2001/XMLSchema#string

Jan Van Der Meer

http://www.w3.org/2001/XMLSchema#string

Marcel G H M Beld

http://www.w3.org/2001/XMLSchema#string

Marcel G W Dijkgraaf

http://www.w3.org/2001/XMLSchema#string

Peter L M Jansen

http://www.w3.org/2001/XMLSchema#string

P2860

Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Hepatitis C virus infection

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients

The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.

Dynamics of hepatitis C viremia following interferon-alpha administration.

P304

857-869

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365520801938917

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Huub C Gelderblom

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5270578

http://www.w3.org/2001/XMLSchema#string

P698

18584525

http://www.w3.org/2001/XMLSchema#string

P921

virology